These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 20458347)

  • 1. Review of topiramate for the treatment of epilepsy in elderly patients.
    Sommer BR; Fenn HH
    Clin Interv Aging; 2010 Apr; 5():89-99. PubMed ID: 20458347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of adjunctive topiramate on cognitive function in patients with epilepsy.
    Lee S; Sziklas V; Andermann F; Farnham S; Risse G; Gustafson M; Gates J; Penovich P; Al-Asmi A; Dubeau F; Jones-Gotman M
    Epilepsia; 2003 Mar; 44(3):339-47. PubMed ID: 12614389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary observations on topiramate in pediatric epilepsies.
    Glauser TA
    Epilepsia; 1997; 38 Suppl 1():S37-41. PubMed ID: 9092958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topiramate: a review of its use in the treatment of epilepsy.
    Lyseng-Williamson KA; Yang LP
    Drugs; 2007; 67(15):2231-56. PubMed ID: 17927286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmarketing experience with topiramate and cognition.
    Tatum WO; French JA; Faught E; Morris GL; Liporace J; Kanner A; Goff SL; Winters L; Fix A;
    Epilepsia; 2001 Sep; 42(9):1134-40. PubMed ID: 11580760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacology of topiramate: a review.
    Garnett WR
    Epilepsia; 2000; 41(S1):61-5. PubMed ID: 10768303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous topiramate: safety and pharmacokinetics following a single dose in patients with epilepsy or migraines taking oral topiramate.
    Clark AM; Kriel RL; Leppik IE; White JR; Henry TR; Brundage RC; Cloyd JC
    Epilepsia; 2013 Jun; 54(6):1106-11. PubMed ID: 23586686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topiramate pharmacokinetics in children and adults with epilepsy: a case-matched comparison based on therapeutic drug monitoring data.
    Battino D; Croci D; Rossini A; Messina S; Mamoli D; Perucca E
    Clin Pharmacokinet; 2005; 44(4):407-16. PubMed ID: 15828853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pooled analysis of adjunctive topiramate in refractory partial epilepsy.
    Peeters K; Adriaenssen I; Wapenaar R; Neto W; Pledger G
    Acta Neurol Scand; 2003 Jul; 108(1):9-15. PubMed ID: 12807387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current data on topiramate].
    Herranz JL
    Rev Neurol; 2000 Jun; 30 Suppl 1():S132-6. PubMed ID: 10904980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical aspects of the use of topiramate in patients with epilepsy.
    Sander JW
    Epilepsia; 1997; 38 Suppl 1():S56-8. PubMed ID: 9092962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of topiramate.
    Bourgeois BF
    J Child Neurol; 2000; 15 Suppl 1():S27-30. PubMed ID: 11218054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
    Contin M; Riva R; Albani F; Avoni P; Baruzzi A
    Ther Drug Monit; 2002 Jun; 24(3):332-7. PubMed ID: 12021622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
    Helmstaedter C; Witt JA
    Epilepsy Behav; 2013 Feb; 26(2):182-7. PubMed ID: 23318473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired verbal fluency under topiramate--evidence for synergistic negative effects of epilepsy, topiramate, and polytherapy.
    Witt JA; Elger CE; Helmstaedter C
    Eur J Neurol; 2013 Jan; 20(1):130-7. PubMed ID: 22827489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic-pharmacodynamic assessment of topiramate dosing regimens for children with epilepsy 2 to <10 years of age.
    Girgis IG; Nandy P; Nye JS; Ford L; Mohanty S; Wang S; Ochalski S; Eerdekens M; Cox E
    Epilepsia; 2010 Oct; 51(10):1954-62. PubMed ID: 20880232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy.
    Privitera MD; Brodie MJ; Mattson RH; Chadwick DW; Neto W; Wang S;
    Acta Neurol Scand; 2003 Mar; 107(3):165-75. PubMed ID: 12614309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate.
    Glauser TA
    Semin Pediatr Neurol; 1997 Mar; 4(1):34-42. PubMed ID: 9097365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors affecting long-term retention of topiramate in patients with chronic epilepsy.
    Lhatoo SD; Wong IC; Sander JW
    Epilepsia; 2000 Mar; 41(3):338-41. PubMed ID: 10714407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive effects of low-dose topiramate monotherapy in epilepsy patients: A 1-year follow-up.
    Lee HW; Jung DK; Suh CK; Kwon SH; Park SP
    Epilepsy Behav; 2006 Jun; 8(4):736-41. PubMed ID: 16647301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.